Pfiz­er launch­ing first US mAb biosim­i­lar with Rem­i­cade knock­off, but you can for­get about any fire sale

Pfiz­er $PFE plans to launch the first mAb copy­cat and the sec­ond biosim­i­lar ever in the US in the next few weeks. But the price …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.